“`html Time to Say Adieu to FISH in Myeloma Diagnostics: NGS Takes Center Stage For decades, fluorescence in situ hybridization (FISH) has been a cornerstone of myeloma diagnostics, used to identify chromosomal abnormalities crucial for risk stratification and treatment planning. Though,a recent surge in the adoption of next-generation sequencing (NGS) is challenging FISH’s dominance. A
Source link